Dr Tanja Mueller

Lecturer

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

My research interest is, broadly speaking, rational use of medicines, mainly focusing on pharmacoepidemiology – particularly drug utilisation – but also comprising related areas such as health policy. Topics include drugs used in cancer and cardiovascular disease; antimicrobial stewardship; drug adherence and treatment outcomes; and electronic record linkage. While mostly applying a range of statistical methods, I am also interest in mixed-methods approaches.

Back to staff profile

Publications

Trigger a surge in hypertension and high cholesterol? A nationwide study on Scotland's post-pandemic prescribing trends and healthcare system recovery
Kurdi Amanj, Millar Morven, Nnabuko Uchenna, McTaggart Stuart, Mueller Tanja, Proud Euan, Melia Barry, Bennie Marion
The 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences 2025 (2025)
Information sources for prescribing three groups of supplementary medicines for paediatric patients with cancer in Scottish paediatric oncology wards : a document analysis study
Alkhlaifat Rahaf, Summers Louise, Weir Natalie Mcfadyen, Mueller Tanja
Research in Social and Administrative Pharmacy Vol 21, pp. e48 (2025)
https://doi.org/10.1016/j.sapharm.2025.06.019
Developing a community pharmacy service to promote adherence to antidepressants : an implementation science approach
Alshammari Hisham, Mueller Tanja, Watson Margaret, McFadyen Weir Natalie
Research in Social and Administrative Pharmacy Vol 21, pp. e53 (2025)
https://doi.org/10.1016/j.sapharm.2025.06.038
Effectiveness of deprescribing tools and interventions in detecting and deprescribing potentially inappropriate medications and their effect on patients' clinical outcomes : a systematic review
Madanat Faisal, Noorsaeed Solafa, Alkhlaifat Rahaf, Mueller Tanja, Kurdi Amanj
Research in Social and Administrative Pharmacy Vol 21, pp. e63 (2025)
https://doi.org/10.1016/j.sapharm.2025.06.072
Introduction of biopharmaceuticals in Europe : a cross-sectional study of early diffusion patterns and data availability
Veszelei Ivar, Godman Brian, Aaltonen Katri, Selke Gisbert W, Garuolienė Kristina, Cangini Agnese, Kurdi Amanj, Teixeira Rodrigues António, Pontes Caridad, Torre Carla, Lunghi Carlotta, Burton Edel, Poplavska Elita, Jónsdóttir Freyja, Petrova Guenka, Langer Irene, Iaru Irina, Odnoletkova Irina, Slabý Juraj, Gvozdanović Katarina, Saastamoinen Leena, Laius Ott, Benkö Ria, Žiogaitė Silvija, McTaggart Stuart, Mueller Tanja, de Pando Thais, Tesař Tomáš, Mitkova Zornitsa, Wettermark Björn
BioDrugs Vol 39, pp. 735-751 (2025)
https://doi.org/10.1007/s40259-025-00732-2
Types of potentially inappropriate medications (PIMs) classes targeted by deprescribing tools and interventions : a systematic reivew
Madanat Faisal, Noorsaeed Solafa, Alkhlaifat Rahaf, Mueller Tanja, Kurdi Amanj
Research in Social and Administrative Pharmacy Vol 21, pp. e63-e64 (2025)
https://doi.org/10.1016/j.sapharm.2025.06.073

More publications

Back to staff profile

Teaching

I teach content across all years of the MPharm degree course, with a focus on information gathering and interpretation; research methods; and communication skills. I also teach critical appraisal, research methods including study designs and data analysis/statistics, and other transferrable skills on the MSc Clinical Pharmacy course. Furthermore, I am actively engaged in supervising undergraduate (MPharm) as well as postgraduate taught (MSc Clin Pharm) and research (MPhil, PhD) students.

My main areas of interest are Public Health, and the intersection of medical/pharmaceutical topics and wider societal issues. In my teaching, I aim to spark interest in research among students, and strive to develop their skills holistically.

Back to staff profile

Professional Activities

European Drug Utilisation Conference (EuroDURG)
Participant
1/7/2025
NORDIC Social Pharmacy Conference 2025
Participant
4/6/2025
NORDIC Social Pharmacy Conference 2025
Organiser
4/6/2025
Chief Scientist's Office CSO (External organisation)
Member
4/2025
European Drug Utilisation Conference (EuroDURG) (Event)
Peer reviewer
2/2025
Exploratory Research in Clinical and Social Pharmacy (Journal)
Peer reviewer
2025

More professional activities

Projects

Cancer Medicines Outcomes Programme - Public Health Scotland
Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
01-Jan-2024 - 31-Jan-2027
Prescribing medicines use in pregnancy: A scoping review protocol
Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
10-Jan-2024 - 14-Jan-2024
PHS Medicines Programme
Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
01-Jan-2023 - 30-Jan-2028
Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care
Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)
01-Jan-2023 - 30-Jan-2027
22/145 Systems Engineering Innovation hubs for Multiple longterm Conditions - Development phase
Maier, Anja (Principal Investigator) Connolly, Patricia (Co-investigator) Gray, Louise (Co-investigator) Inns, Tom (Co-investigator) Kurdi, Amanj (Co-investigator) Maguire, Roma (Co-investigator) Mehnen, Jorn (Co-investigator) Michie, Craig (Co-investigator) Mueller, Tanja (Co-investigator) Picanco Rodrigues, Vinicius (Co-investigator) Tachtatzis, Christos (Co-investigator) Whitfield, Ian (Co-investigator)
01-Jan-2023 - 31-Jan-2025
Cancer Medicines Outcomes Programme Interim 23-24
Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Kavanagh, Kimberley (Co-investigator) Mueller, Tanja (Co-investigator) Dunlop, Emma (Principal Investigator) Fontes, Pedro (Researcher) Csoban, Tunde (Researcher)
Continuation of funding for the CMOP programme for 23-24
01-Jan-2023 - 31-Jan-2024

More projects

Back to staff profile

Contact

Dr Tanja Mueller
Lecturer
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: tanja.muller@strath.ac.uk
Tel: 548 2865